MYCN-Related Suppression of Functional CD44 Expression Enhances Tumorigenic Properties of Human Neuroblastoma Cells
- 1 November 2000
- journal article
- research article
- Published by Elsevier BV in Experimental Cell Research
- Vol. 260 (2), 396-403
- https://doi.org/10.1006/excr.2000.5007
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Differentiation and prognosis of neuroblastoma in correlation to the expression of CD44sEuropean Journal of Cancer, 1995
- CB44 expression and modulation on human neuroblastoma tumours and cell linesEuropean Journal of Cancer, 1995
- Glycosylation of CD44 negatively regulates its recognition of hyaluronan.The Journal of Experimental Medicine, 1995
- Role of CD44 cytoplasmic domain in hyaluronan bindingEuropean Journal of Immunology, 1995
- Altered growth and phenotype in clonalmycN transfectants of the sk-n-sh neuroblastoma cell lineInternational Journal of Cancer, 1994
- Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function.The Journal of cell biology, 1994
- Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.The Journal of Experimental Medicine, 1994
- Distinct effects of two CD44 isoforms on tumor growth in vivo.The Journal of Experimental Medicine, 1991
- Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.The Journal of Experimental Medicine, 1990
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990